Papers
1
Total Citations
20
H-Index
1
About
Dr. Weixia Yu is a leading researcher in urologic oncology and medical imaging, with a focus on improving prostate cancer prognosis through advanced radiological techniques. Her work bridges the gap between high-resolution imaging and surgical pathology, particularly in the context of robotic-assisted radical prostatectomy. In her highly cited 2017 study, Dr. Yu demonstrated how 3 Tesla volumetric magnetic resonance imaging (MRI) can predict biochemical recurrence—a critical indicator of cancer relapse—by correlating imaging findings with whole-mount histopathology. This research, which has garnered 20 citations, established key clinical and MRI-based variables that enhance post-surgical risk stratification. By integrating multiparametric MRI data with pathological outcomes, Dr. Yu’s contributions have helped refine non-invasive prognostic tools, reducing the need for invasive biopsies and enabling more personalized treatment planning. Her work is instrumental for clinicians and researchers seeking to leverage imaging biomarkers to improve long-term outcomes in prostate cancer patients, positioning her as a pivotal figure in the evolution of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1